Skip to main content

Table 2 Concomitant medication use in the per-protocol (PP) population

From: Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)

 

Viral diarrhea

N = 2786

n (%)

AAD

N = 130

n (%)

Total

N = 2916

n (%)

At least one concomitant medication

1389 (49.9)

107 (82.3)

1496 (51.3)

ORT

778 (27.9)

40 (30.8)

818 (28.1)

Zinc supplementation

715 (25.7)

33 (25.4)

748 (25.7)

Antibiotics for conditions other than diarrhea

303 (10.9)

66 (50.8)

369 (12.7)

Other concomitant medications

299 (10.7)

34 (26.2)

333 (11.4)

Nutritional preparations containing prebiotics or probiotics

24 (0.86)

2 (1.5)

26 (0.89)

  1. Percentages are calculated as n/N
  2. AAD, antibiotic-associated diarrhea; ORT, oral rehydration therapy